期刊
EQUINE VETERINARY JOURNAL
卷 53, 期 1, 页码 94-101出版社
WILEY
DOI: 10.1111/evj.13268
关键词
horse; mare; yeast; reproductive candidiasis; eugenol; voriconazole; synergistic activity
资金
- Amol University of Special Modern Technologies
- University of Tehran
The study demonstrated synergistic effects of eugenol in combination with voriconazole against genital Candida isolates, providing potential therapeutic implications for cases of azole resistance.
Background Due to the limited range of antifungals available to treat genital Candida infections and the emergence of resistant isolates, attention has focused on the antifungal potency of natural compounds with promising biological properties. Objectives To examine whether eugenol synergises the in vitro efficacy of voriconazole against Candida strains isolated from the genital tract of mares. Study design In vitro experiment. Methods The antifungal activity of eugenol and voriconazole was evaluated using the broth microdilution assay (CLSI- M27-A3). Synergism of eugenol and voriconazole against genital Candida isolates was evaluated by the microdilution checkerboard method. Results Minimum inhibitory concentration (MIC) values for eugenol and voriconazole ranged from 400 to 800 mu g/mL and 1 to 8 mu g/mL, respectively, for C. tropicalis isolates, and from 200 to 400 mu g/mL for eugenol and 2 to 16 mu g/mL for voriconazole against C. krusei isolates. Eugenol decreased the arithmetic mean MIC for voriconazole against C. tropicalis and C. krusei isolates from 2.66 to 0.46 mu g/mL and 7.77 to 0.41 mu g/mL respectively. The fractional inhibitory concentration index (FICI) values for the eugenol-voriconazole combination ranged from 0.25 to 0.88 and 0.19 to 0.63 for C. tropicalis and C. krusei isolates respectively. A synergistic effect of eugenol in combination with voriconazole was observed for 83.3% of C. tropicalis and 77.7% of C. krusei isolates. Antagonistic activity was not seen in any of the isolates tested. Main limitations Since in vitro antifungal susceptibility tests are not systematic analyses, any selection bias could influence the results. In addition, in vitro susceptibility does not uniformly predict clinical success in vivo. Conclusions Eugenol showed fungistatic and fungicidal effects against genital Candida isolates and, in combination, synergised the antifungal effects of voriconazole. The eugenol-voriconazole combination can lay the foundation for a therapeutic approach against isolates in which azole resistance has increased over time.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据